Roche Diagnostics held 'Roche Day' in Tashkent, a professional event that brought together healthcare specialists, clinicians, laboratory experts, and heads of medical organizations to discuss modern diagnostic approaches, digital transformation, and international experience exchange.
The event focused on solutions aimed at earlier disease detection, improving clinical decision accuracy, and supporting the efficiency of laboratories and healthcare organizations. The company presented developments in priority areas, including modern approaches to diagnosing Alzheimer's disease, cardiovascular diseases, and digital algorithms to support clinical decisions.
'Roche Day' served as a platform for professional dialogue on how modern diagnostic technologies assist specialists at all stages of the patient journey – from screening and early disease detection to prognosis assessment and therapy effectiveness monitoring. Participants also discussed the importance of laboratory automation, which enhances the accuracy and reproducibility of results, reduces human error, and helps build more efficient processes in the patient's interest.
'Today, IVD diagnostics is the foundation of modern medicine. While accounting for an average of 2% of healthcare costs, laboratory test results underpin more than 70% of all clinical decisions. For us at Roche Diagnostics, this means a huge responsibility: ensuring the accuracy of data on which patient health and the efficiency of the entire system directly depend,' said Zhanar Kanybekova, Head of Healthcare Innovation at Roche Diagnostics Central Asia and Caucasus.
Special attention was paid to Alzheimer's disease and the importance of early detection of cognitive impairment. Participants discussed the growing relevance of this area for healthcare systems, the role of objective diagnostic data, and the importance of timely patient referral at the first signs of cognitive decline.
'Alzheimer's disease and other forms of dementia require earlier attention. It is important not to dismiss initial cognitive changes as merely age-related, but to refer the patient for further evaluation in a timely manner. The earlier a specialist receives additional diagnostic tools, the greater the opportunities for timely help to the patient and their family,' emphasized Zhibek Zholdasova, Candidate of Medical Sciences and psychotherapist.
Roche Diagnostics considers Uzbekistan a strategically important direction for the development of modern diagnostics and professional cooperation with the medical community. The company continues to develop solutions that help doctors, laboratory specialists, and healthcare managers obtain reliable diagnostic information, optimize workflows, and support informed decision-making in clinical practice.
Holding 'Roche Day' in Tashkent confirmed the professional community's interest in modern diagnostic solutions capable of boosting healthcare development and expanding access to advanced technologies in Uzbekistan.
Source: kun.uz